LRRK2 and Parkinson disease: While these data provide direct evidence of how dysfunction of astrocytes carrying the G2019S LRRK2 mutation can lead to neurodegeneration associated with PD, whether the specific mutation altered the inflammatory profile of the corresponding PD astrocytes had not been examined.